Absolute Coronary Flow in Patients With Heart Failure With Reduced Ejection Fraction and Left Bundle Branch Block With Cardiac Resynchronization Therapy

Recruiting Observational Study
Left Bundle-Branch Block Heart Failure Cardiac Resynchronization Therapy Dilated Cardiomyopathy
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
60 (estimated)
Sponsor
Ashkan Eftekhari · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Cardiac resynchronization therapy (CRT) is an effective therapeutic strategy in patients with symptomatic heart failure (HF) patients with LVEF of ≤35% and left bundle branch block (LBBB). However, approximately one-third of CRT-recipients do not improve after therapy (non-responders), despite meeting the required criteria. Previous studies have documented that the positive respons to CRT is rela…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age \> 18 * QRS ≥ 150 ms before implantation * Heart failure because of dilated cardiomypathy * Sinus rhythm * Stable medical therapy * LBBB * CRT device Exclusion Criteria: * eGFR \< 30 ml/min * Severe valvular heart disease * Permanent atrial fibrillation or atrial flutter…
Contacts

Ashkan Eftekhari

004528973764

asef@rn.dk

CONTACT

Sanna Gunnarstein

004542918950

s.gunnarstein@rn.dk

CONTACT